Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Nivolumab-ipilimumab combo plus surgery improves survival in HCC

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

11 Feb 2026 bởiStephen Padilla

Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.

Nivolumab-ipilimumab combo plus surgery improves survival in HCC

11 Feb 2026
Harnessing the microbiome for autism: From diagnosis to treatment

Harnessing the microbiome for autism: From diagnosis to treatment

11 Feb 2026